← Eichor
Study identifier: NCT05563623 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Beijing Angle Closure Progression Study

Condition: Angle-Closure Glaucoma  ·  Sponsor: Peking University People's Hospital

PhaseN/A
Planned participants825
Who can joinAll sexes, 40 Years to 75 Years
Healthy volunteersNo

About this study

The Beijing angle closure progression study (BAPS) aims to explore the 5-year incidence of PACS progressing to PAC or PACG and to determine the possible risk factors of disease progression, which may provide the evidence for choosing the accurate strategies in the management of PACS.

This description comes directly from the study's public registry record.

Talk to the study team

Huijuan Wu, M.D. Ph.D.  ·  8613811293109  ·  dr_wuhuijuan@126.com

Always discuss trial participation with your own doctor first.

Locations (1)

Peking University People's HospitalBeijing, Beeijing, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05563623